| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 310 | 252 | 284 | 313 | 310 | 311 | 339 | 325 | 374 | 370 | 364 | 382 | |
Growth YoY Revenue Growth YoY% | 0.0 | -21.3 | -5.7 | 2.8 | -0.1 | 23.2 | 19.3 | 3.7 | 20.7 | 19.1 | 7.4 | 17.7 |
| 208 | 185 | 236 | 199 | 186 | 230 | 248 | 205 | 263 | 235 | 264 | 230 | |
| 102 | 67 | 48 | 114 | 123 | 81 | 90 | 120 | 110 | 136 | 100 | 152 | |
OPM OPM% | 32.8 | 26.7 | 17.0 | 36.4 | 39.9 | 26.0 | 26.7 | 37.0 | 29.6 | 36.6 | 27.4 | 39.8 |
| 5 | 2 | -18 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | 36 | 4 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
PBT PBTCr | 100 | 63 | 23 | 111 | 122 | 79 | 89 | 119 | 109 | 133 | 129 | 150 |
| 28 | 16 | 6 | 29 | 31 | 17 | 23 | 30 | 31 | 39 | 33 | 39 | |
| 72 | 47 | 17 | 82 | 91 | 61 | 66 | 89 | 78 | 95 | 96 | 112 | |
Growth YoY PAT Growth YoY% | -6.2 | -21.3 | -43.7 | 25.6 | 26.1 | 31.4 | 294.4 | 7.5 | -14.6 | 54.6 | 45.3 | 25.9 |
NPM NPM% | 23.3 | 18.4 | 5.9 | 26.3 | 29.3 | 19.7 | 19.5 | 27.3 | 20.8 | 25.5 | 26.4 | 29.1 |
| 43.4 | 28.0 | 9.5 | 49.6 | 54.8 | 36.9 | 39.9 | 53.3 | 46.7 | 57.0 | 57.9 | 67.2 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 310 | 252 | 284 | 313 | 310 | 311 | 339 | 325 | 374 | 370 | 364 | 382 | |
Growth YoY Revenue Growth YoY% | 0.0 | -21.3 | -5.7 | 2.8 | -0.1 | 23.2 | 19.3 | 3.7 | 20.7 | 19.1 | 7.4 | 17.7 |
| 208 | 185 | 236 | 199 | 186 | 230 | 248 | 205 | 263 | 235 | 264 | 230 | |
| 102 | 67 | 48 | 114 | 123 | 81 | 90 | 120 | 110 | 136 | 100 | 152 | |
OPM OPM% | 32.8 | 26.7 | 17.0 | 36.4 | 39.9 | 26.0 | 26.7 | 37.0 | 29.6 | 36.6 | 27.4 | 39.8 |
| 5 | 2 | -18 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | 36 | 4 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
PBT PBTCr | 100 | 63 | 23 | 111 | 122 | 79 | 89 | 119 | 109 | 133 | 129 | 150 |
| 28 | 16 | 6 | 29 | 31 | 17 | 23 | 30 | 31 | 39 | 33 | 39 | |
| 72 | 47 | 17 | 82 | 91 | 61 | 66 | 89 | 78 | 95 | 96 | 112 | |
Growth YoY PAT Growth YoY% | -6.2 | -21.3 | -43.7 | 25.6 | 26.1 | 31.4 | 294.4 | 7.5 | -14.6 | 54.6 | 45.3 | 25.9 |
NPM NPM% | 23.3 | 18.4 | 5.9 | 26.3 | 29.3 | 19.7 | 19.5 | 27.3 | 20.8 | 25.5 | 26.4 | 29.1 |
| 43.4 | 28.0 | 9.5 | 49.6 | 54.8 | 36.9 | 39.9 | 53.3 | 46.7 | 57.0 | 57.9 | 67.2 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 940 | 993 | 698 | 849 | 1,356 | 1,009 | 1,114 | 1,230 | 1,151 | 934 | 1,408 | 1,491 |
Growth Revenue Growth% | 8.3 | 5.7 | -29.7 | 21.6 | -25.6 | 10.5 | 10.3 | -6.4 | 50.7 | 16.1 | ||
| 856 | 877 | 621 | 701 | 1,040 | 763 | 847 | 905 | 845 | 616 | 951 | 992 | |
| 83 | 116 | 77 | 148 | 315 | 246 | 268 | 325 | 306 | 318 | 457 | 498 | |
OPM OPM% | 8.9 | 11.6 | 11.0 | 17.4 | 23.3 | 24.4 | 24.0 | 26.4 | 26.6 | 34.1 | 32.4 | 33.4 |
| 23 | 24 | 41 | 31 | 69 | 18 | 13 | 18 | -5 | 10 | 48 | ||
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
Depreciation DepreciationCr | 23 | 25 | 19 | 21 | 29 | 30 | 27 | 28 | 27 | 17 | 24 | 24 |
PBT PBTCr | 83 | 115 | 99 | 158 | 355 | 233 | 253 | 314 | 273 | 312 | 450 | 521 |
| 30 | 36 | 38 | 56 | 101 | 56 | 61 | 85 | 72 | 77 | 123 | 141 | |
PAT PATCr | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 229 | 201 | 234 | 327 | 380 |
Growth PAT Growth% | 23.9 | 47.7 | -22.9 | 66.7 | -30.4 | 8.9 | 19.2 | -12.4 | 39.5 | 23.8 | ||
NPM NPM% | 5.7 | 8.0 | 8.7 | 12.0 | 18.7 | 17.5 | 17.3 | 18.7 | 17.5 | 25.1 | 23.2 | 25.5 |
| 32.3 | 47.7 | 56.6 | 505.3 | 153.1 | 106.5 | 116.0 | 138.2 | 121.1 | 141.2 | 196.9 | 228.8 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 940 | 993 | 698 | 849 | 1,356 | 1,009 | 1,114 | 1,230 | 1,151 | 934 | 1,408 | 1,491 |
Growth Revenue Growth% | 8.3 | 5.7 | -29.7 | 21.6 | -25.6 | 10.5 | 10.3 | -6.4 | 50.7 | 16.1 | ||
| 856 | 877 | 621 | 701 | 1,040 | 763 | 847 | 905 | 845 | 616 | 951 | 992 | |
| 83 | 116 | 77 | 148 | 315 | 246 | 268 | 325 | 306 | 318 | 457 | 498 | |
OPM OPM% | 8.9 | 11.6 | 11.0 | 17.4 | 23.3 | 24.4 | 24.0 | 26.4 | 26.6 | 34.1 | 32.4 | 33.4 |
| 23 | 24 | 41 | 31 | 69 | 18 | 13 | 18 | -5 | 10 | 48 | ||
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
Depreciation DepreciationCr | 23 | 25 | 19 | 21 | 29 | 30 | 27 | 28 | 27 | 17 | 24 | 24 |
PBT PBTCr | 83 | 115 | 99 | 158 | 355 | 233 | 253 | 314 | 273 | 312 | 450 | 521 |
| 30 | 36 | 38 | 56 | 101 | 56 | 61 | 85 | 72 | 77 | 123 | 141 | |
PAT PATCr | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 229 | 201 | 234 | 327 | 380 |
Growth PAT Growth% | 23.9 | 47.7 | -22.9 | 66.7 | -30.4 | 8.9 | 19.2 | -12.4 | 39.5 | 23.8 | ||
NPM NPM% | 5.7 | 8.0 | 8.7 | 12.0 | 18.7 | 17.5 | 17.3 | 18.7 | 17.5 | 25.1 | 23.2 | 25.5 |
| 32.3 | 47.7 | 56.6 | 505.3 | 153.1 | 106.5 | 116.0 | 138.2 | 121.1 | 141.2 | 196.9 | 228.8 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Reserves ReservesCr | 575 | 647 | 717 | 1,524 | 890 | 687 | 600 | 734 | 522 | 520 | 508 | 641 |
| 165 | 186 | 225 | 193 | 227 | 239 | 232 | 304 | 219 | 215 | 255 | 297 | |
| 27 | 29 | 33 | 27 | 42 | 43 | 40 | 46 | 37 | 42 | 62 | 60 | |
| 784 | 879 | 991 | 1,759 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 | |
| 572 | 636 | 752 | 1,534 | 954 | 727 | 608 | 796 | 524 | 526 | 556 | 720 | |
| 212 | 243 | 239 | 225 | 222 | 259 | 280 | 305 | 270 | 268 | 285 | 295 | |
| 784 | 879 | 991 | 1,759 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Reserves ReservesCr | 575 | 647 | 717 | 1,524 | 890 | 687 | 600 | 734 | 522 | 520 | 508 | 641 |
| 165 | 186 | 225 | 193 | 227 | 239 | 232 | 304 | 219 | 215 | 255 | 297 | |
| 27 | 29 | 33 | 27 | 42 | 43 | 40 | 46 | 37 | 42 | 62 | 60 | |
| 784 | 879 | 991 | 1,759 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 | |
| 572 | 636 | 752 | 1,534 | 954 | 727 | 608 | 796 | 524 | 526 | 556 | 720 | |
| 212 | 243 | 239 | 225 | 222 | 259 | 280 | 305 | 270 | 268 | 285 | 295 | |
| 784 | 879 | 991 | 1,759 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 83 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | 228 | 169 | 338 | |
| -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | -7 | 10 | 1 | |
| -12 | -15 | -22 | -30 | -883 | -387 | -289 | -98 | -418 | -235 | -344 | |
Net Cash Flow Net Cash FlowCr | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | -197 | -56 | -5 |
Free Cash Flow Free Cash FlowCr | 38 | 75 | 24 | -157 | 212 | 196 | 132 | 198 | 207 | 168 | 323 |
CFO To PAT CFO To PAT% | 155.8 | 135.3 | 87.9 | -128.2 | 92.6 | 139.8 | 88.0 | 102.8 | 113.6 | 72.0 | 103.3 |
CFO To EBITDA CFO To EBITDA% | 100.0 | 92.6 | 69.7 | -88.0 | 74.6 | 100.5 | 63.3 | 72.7 | 74.6 | 53.0 | 74.0 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 83 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | 228 | 169 | 338 | |
| -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | -7 | 10 | 1 | |
| -12 | -15 | -22 | -30 | -883 | -387 | -289 | -98 | -418 | -235 | -344 | |
Net Cash Flow Net Cash FlowCr | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | -197 | -56 | -5 |
Free Cash Flow Free Cash FlowCr | 38 | 75 | 24 | -157 | 212 | 196 | 132 | 198 | 207 | 168 | 323 |
CFO To PAT CFO To PAT% | 155.8 | 135.3 | 87.9 | -128.2 | 92.6 | 139.8 | 88.0 | 102.8 | 113.6 | 72.0 | 103.3 |
CFO To EBITDA CFO To EBITDA% | 100.0 | 92.6 | 69.7 | -88.0 | 74.6 | 100.5 | 63.3 | 72.7 | 74.6 | 53.0 | 74.0 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,293 | 1,656 | 2,139 | 5,120 | 6,751 | 9,286 | 6,951 | 8,713 | 8,382 | 8,536 | 7,965 | 9,278 |
Price To Earnings Price To Earnings | 25.3 | 20.9 | 22.8 | 6.1 | 39.9 | 52.5 | 36.1 | 38.0 | 41.7 | 27.3 | 24.4 | 24.4 |
Price To Sales Price To Sales | 1.4 | 1.7 | 3.1 | 6.0 | 5.0 | 9.2 | 6.2 | 7.1 | 7.3 | 8.3 | 5.1 | 6.2 |
Price To Book Price To Book | 2.2 | 2.5 | 2.9 | 3.3 | 7.5 | 13.2 | 11.3 | 11.6 | 15.6 | 15.9 | 15.2 | 14.1 |
EV To EBITDA EV To EBITDA | 13.2 | 11.9 | 24.2 | 26.2 | 19.4 | 35.9 | 24.8 | 25.5 | 26.6 | 26.2 | 17.0 | 18.0 |
GPM GPM% | 47.0 | 52.6 | 56.7 | 56.3 | 56.7 | 58.8 | 60.0 | 62.8 | 64.1 | 66.2 | ||
OPM OPM% | 8.9 | 11.6 | 11.0 | 17.4 | 23.3 | 24.4 | 24.0 | 26.4 | 26.6 | 34.1 | 32.4 | 33.4 |
NPM NPM% | 5.7 | 8.0 | 8.7 | 12.0 | 18.7 | 17.5 | 17.3 | 18.7 | 17.5 | 25.1 | 23.2 | 25.5 |
ROCE ROCE% | 14.1 | 17.4 | 13.5 | 10.3 | 39.1 | 32.9 | 41.0 | 41.3 | 50.0 | 57.3 | 85.9 | 79.3 |
ROE ROE% | 9.1 | 11.9 | 8.3 | 6.6 | 28.0 | 25.1 | 31.2 | 30.6 | 37.3 | 43.7 | 62.3 | 57.7 |
ROA ROA% | 6.8 | 9.0 | 6.2 | 5.8 | 21.6 | 17.9 | 21.7 | 20.8 | 25.3 | 29.5 | 38.9 | 37.4 |
| Financial Year | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,293 | 1,656 | 2,139 | 5,120 | 6,751 | 9,286 | 6,951 | 8,713 | 8,382 | 8,536 | 7,965 | 9,278 |
Price To Earnings Price To Earnings | 25.3 | 20.9 | 22.8 | 6.1 | 39.9 | 52.5 | 36.1 | 38.0 | 41.7 | 27.3 | 24.4 | 24.4 |
Price To Sales Price To Sales | 1.4 | 1.7 | 3.1 | 6.0 | 5.0 | 9.2 | 6.2 | 7.1 | 7.3 | 8.3 | 5.1 | 6.2 |
Price To Book Price To Book | 2.2 | 2.5 | 2.9 | 3.3 | 7.5 | 13.2 | 11.3 | 11.6 | 15.6 | 15.9 | 15.2 | 14.1 |
EV To EBITDA EV To EBITDA | 13.2 | 11.9 | 24.2 | 26.2 | 19.4 | 35.9 | 24.8 | 25.5 | 26.6 | 26.2 | 17.0 | 18.0 |
GPM GPM% | 47.0 | 52.6 | 56.7 | 56.3 | 56.7 | 58.8 | 60.0 | 62.8 | 64.1 | 66.2 | ||
OPM OPM% | 8.9 | 11.6 | 11.0 | 17.4 | 23.3 | 24.4 | 24.0 | 26.4 | 26.6 | 34.1 | 32.4 | 33.4 |
NPM NPM% | 5.7 | 8.0 | 8.7 | 12.0 | 18.7 | 17.5 | 17.3 | 18.7 | 17.5 | 25.1 | 23.2 | 25.5 |
ROCE ROCE% | 14.1 | 17.4 | 13.5 | 10.3 | 39.1 | 32.9 | 41.0 | 41.3 | 50.0 | 57.3 | 85.9 | 79.3 |
ROE ROE% | 9.1 | 11.9 | 8.3 | 6.6 | 28.0 | 25.1 | 31.2 | 30.6 | 37.3 | 43.7 | 62.3 | 57.7 |
ROA ROA% | 6.8 | 9.0 | 6.2 | 5.8 | 21.6 | 17.9 | 21.7 | 20.8 | 25.3 | 29.5 | 38.9 | 37.4 |
| Market CapitalizationMkt CapCr | 46,207 | 17,640 | 15,419 | 9,278 | 7,928 | 7,384 | 4,784 |
| Close PriceClose₹ | 2,727.60 | 3,856.00 | 6,167.50 | 5,589.50 | 3,442.40 | 3,206.10 | 1,367.60 |
| IndustryIndustry | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs |
| Price To EarningsPE | 40.85 | 20.53 | 86.76 | 24.43 | 28.35 | 20.26 | |
| Price To SalesPS | 11.11 | 6.65 | 5.93 | 6.22 | 8.10 | 4.05 | 14.22 |
| RevenueRevenueCr | 4,159 | 2,654 | 2,602 | 1,491 | 979 | 1,822 | 336 |
| Revenue Growth TTMRev Gr TTM% | 12.1% | 11.8% | 29.7% | 16.1% | 22.7% | -5.7% | -5.2% |
| PAT Growth TTMPAT Gr TTM% | 20.0% | 2.4% | -10.8% | 23.8% | 28.4% | 2.3% | -103.7% |
| Market CapitalizationMkt CapCr | 46,207 | 17,640 | 15,419 | 9,278 | 7,928 | 7,384 | 4,784 |
| Close PriceClose₹ | 2,727.60 | 3,856.00 | 6,167.50 | 5,589.50 | 3,442.40 | 3,206.10 | 1,367.60 |
| IndustryIndustry | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs | Pharma MNC Bulk Drugs |
| Price To EarningsPE | 40.85 | 20.53 | 86.76 | 24.43 | 28.35 | 20.26 | |
| Price To SalesPS | 11.11 | 6.65 | 5.93 | 6.22 | 8.10 | 4.05 | 14.22 |
| RevenueRevenueCr | 4,159 | 2,654 | 2,602 | 1,491 | 979 | 1,822 | 336 |
| Revenue Growth TTMRev Gr TTM% | 12.1% | 11.8% | 29.7% | 16.1% | 22.7% | -5.7% | -5.2% |
| PAT Growth TTMPAT Gr TTM% | 20.0% | 2.4% | -10.8% | 23.8% | 28.4% | 2.3% | -103.7% |